Fundz

Surf Therapeutics raises $6M in a seed funding round following positive clinical trial results for its arthritis treatment, enabling further advancements in clinical evidence.

PRIVATEMar 17, 2026

Amount Raised

$6 Million

Round Type

Seed

BiotechnologyHealth CareTherapeutics

Investors

TMC Venture FundSosv

Description

Surf Therapeutics, a clinical-stage company developing therapies for immune-mediated diseases, has secured additional financing, bringing total funding to approximately $6 million. This funding follows positive first-in-human study results demonstrating significant reductions in pro-inflammatory cytokines in arthritis patients. The company plans to publish its data and present at EULAR 2026. This financing will help strengthen their clinical evidence as they prepare for a pivotal trial.

Quick answer

Surf Therapeutics raised $6 Million in a Seed round, dated March 17, 2026. Investors: TMC Venture Fund and Sosv.

How much did Surf Therapeutics raise?
Surf Therapeutics raised $6 Million in a Seed round on March 17, 2026.
Who invested in Surf Therapeutics?
TMC Venture Fund and Sosv are named as investors in this round.
What does Surf Therapeutics do?
Surf Therapeutics, Inc. is a clinical-stage company pioneering the development of non-invasive ultrasound neuromodulation technologies to modulate immune-related pathways.
Who are the decision-makers at Surf Therapeutics?
Fundz holds 1 contact at Surf Therapeutics, including the Founder / CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Surf Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • mbiomics raised $35M (Series A) on April 29, 2026.
  • Coultreon Biopharma raised $125M (Series A) on April 28, 2026.
  • NewcelX raised $3.4M on April 27, 2026.
  • Lighthouse Pharmaceuticals raised $15M (Series A) on April 22, 2026.
  • Tortugas Neuroscience raised $106M (Series A) on April 21, 2026.
  • Beeline Medicines raised $300M (Series A) on April 16, 2026.

Who to call at Surf Therapeutics, and when

A new round usually means Surf Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Surf Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Surf Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Surf Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Surf Therapeutics

About

Surf Therapeutics, Inc. is a clinical-stage company pioneering the development of non-invasive ultrasound neuromodulation technologies to modulate immune-related pathways. Its SUSTAIN™ platform is designed to engage the body’s natural anti-inflammatory pathway without surgery or implanted hardware, enabling safe, at-home use and scalable access to therapy.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Surf Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNishant D., Founder / CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Surf Therapeutics's next move

See what Strategic adds

Surf Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.